Forbes September 29, 2024
Andrew Wight

Brazilian researchers have topped a bioinformatics competition looking to find already-approved drugs that could function as treatments for Covid-19.

The need for new treatments has not waned: the virus was still the 10th highest cause of death in the US in 2023 according to figures from the Centers for Disease Control and Prevention.

Karina dos Santos Machado, an associate professor at Universidade Federal do Rio Grande in Brazil, led the team that topped a competition help by Canadian nonprofit biotech organization Conscience finding the most molecules that may lead to a new treatment effective against all coronaviruses.

Machado explains that drug discovery can be expensive and long , so re-purposing existing medicines for new uses can streamline this process.

“We...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Public Health / COVID, Technology
Scale AI CEO says China has quickly caught the U.S. with the DeepSeek open-source model
Anthropic CEO Sees AI-Powered Advances Doubling Human Lifespans
Health care in transition: Trends shaping 2025
How To Smartly (And Safely) Leverage GenAI In Business
Capcom testing generative AI to manage “tens of thousands of ideas”

Share This Article